Papp KA, Yeung J, Shear N, Albrecht L, Lynde C, Zhang J, Zhao Y, Parno J, Mendelsohn AM, Gooderham M. Early and Maintained Response Levels in Psoriasis Patients Treated with Tildrakizumab. J of Skin [Internet]. 2020 Sep. 2 [cited 2024 Jul. 3];4(5):s41. Available from: https://jofskin.org/33014/index.php/skin/article/view/990